↓ Skip to main content

Cochrane Database of Systematic Reviews

Daclizumab for relapsing remitting multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, December 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (62nd percentile)

Mentioned by

blogs
1 blog
twitter
6 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
94 Mendeley
Title
Daclizumab for relapsing remitting multiple sclerosis
Published in
Cochrane database of systematic reviews, December 2013
DOI 10.1002/14651858.cd008127.pub4
Pubmed ID
Authors

Jia Liu, Lu-Ning Wang, Siyan Zhan, Yinyin Xia

Abstract

Monoclonal antibodies such as daclizumab could be a possible alternative immunotherapy to interferon beta treatment in people with multiple sclerosis (MS). It blocks the interleukin-2 receptor alpha subunit (CD25), and seems to be beneficial to patients with relapsing remitting multiple sclerosis (RRMS) in clinical and magnetic resonance imaging (MRI) measures of outcomes.This is an update of a Cochrane review first published in 2010, and previously updated in 2012.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 1%
Brazil 1 1%
Unknown 92 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 19 20%
Student > Bachelor 12 13%
Student > Postgraduate 7 7%
Other 7 7%
Student > Ph. D. Student 7 7%
Other 17 18%
Unknown 25 27%
Readers by discipline Count As %
Medicine and Dentistry 32 34%
Nursing and Health Professions 7 7%
Neuroscience 5 5%
Social Sciences 4 4%
Agricultural and Biological Sciences 4 4%
Other 11 12%
Unknown 31 33%

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2020.
All research outputs
#1,647,852
of 16,775,501 outputs
Outputs from Cochrane database of systematic reviews
#4,127
of 11,590 outputs
Outputs of similar age
#26,769
of 269,526 outputs
Outputs of similar age from Cochrane database of systematic reviews
#61
of 160 outputs
Altmetric has tracked 16,775,501 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,590 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.4. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 269,526 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 160 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.